Data / Form D filings / Delex Healthcare Group, Inc.
Delex Healthcare Group, Inc.: Form D filings
Delex Healthcare Group, Inc., a pharmaceuticals company in New York, NY, filed 4 Form D notices with the SEC between 2022 and 2023. The latest, on April 14, 2023, reports an offering of no set size with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 800 THIRD AVENUE SUITE A #1359, New York, NY, 10022
- Phone
- (775) 391-3237
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1909093
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Apr 14, 2023 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Mar 31, 2022 | New notice | $20,000,000 | $0 | $20,000,000 | 0 | Yet to occur | sec.gov |
| Mar 29, 2022 | New notice | $20,000,000 | $0 | $20,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| J. de Ruyter Coching Oroceo | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Apr 10, 2023 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Delex Healthcare Group, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.